Teprotumumab
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for Teprotumumab, covering 2017-08-30 to 2026-02-27. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Teprotumumab (AMG 632) Administered Intravenously in Healthy Chinese Participants [Phase 1]